| First Author | Adlat S | Year | 2022 |
| Journal | Int Immunopharmacol | Volume | 105 |
| Pages | 108559 | PubMed ID | 35091337 |
| Mgi Jnum | J:327467 | Mgi Id | MGI:6890280 |
| Doi | 10.1016/j.intimp.2022.108559 | Citation | Adlat S, et al. (2022) Heterozygous loss of Dip2B enhances tumor growth and metastasis by altering immune microenvironment. Int Immunopharmacol 105:108559 |
| abstractText | Cancer is caused by abnormal cell growth and metastasis to other tissues. Development of cancers is complex and underlining mechanisms are mostly unknown. Disco-interacting protein 2 homolog B (DIP2B) is a member of Dip2. There have been reports suggesting that Dip2B may participate in tumor growth and development. However, direct link between DIP2B and cancer development is missing. In this study, Dip2b(tm1a/+) heterozygous knockout mouse model was used to investigate tumor growth and metastasis. Results show that one allele knockout of Dip2B significantly promoted tumor growth and metastasis, decreased tumor cell apoptosis and reduced immune cell infiltration in tumors, most likely by altering immune system that includes reduction of macrophage and cytotoxic T-cells infiltration into tumor microenvironment. |
